|
The Disadvantage Exposome as a Driver of Alzheimer’s Disease Pathology |
1F99NS130922-01 |
|
NINDS |
2022 |
|
Enhancing Cognitive Resilience In Parkinsons Disease: Role Of Antiaging Protein Klotho |
1K23NS123506-01A1 |
|
NINDS |
2022 |
|
Cerebellar cholinergic connections as a biomarker of dementia and gait impairment in Parkinson disease |
1K23NS125107-01 |
|
NINDS |
2022 |
|
In vivo synaptic and dopamine transporter imaging in Parkinsons disease |
1R01NS124819-01A1 |
|
NINDS |
2022 |
|
Non invasive in vivo imaging of pathological fibrin deposition in the human brain |
1R21NS126737-01 |
|
NINDS |
2022 |
|
Determinants of Alzheimers Disease in Atrial Fibrillation apart from Stroke: The NOMINATE Study |
1R21NS126967-01 |
|
NINDS |
2022 |
|
Neuroinflammation in Cerebral Small Vessel Disease using PET/MR Imaging |
1R21NS127425-01 |
|
NINDS |
2022 |
|
Acute Ischemic Tissue Evolution and Implications for Imaging Selection of Patients for Therapy and Clinical Trials using Sex-Disaggregated Data |
1R21NS130494-01 |
|
NINDS |
2022 |
|
Defining the Role of Post-TBI Sleep Disruption in the Development of CTE and Alzheimers Disease-Related Neuropathology |
1RF1NS128966-01 |
|
NINDS |
2022 |
|
Defining the Role of Post-TBI Sleep Disruption in the Development of CTE and Alzheimers Disease-Related Neuropathology |
1RF1NS128966-01 |
|
NINDS |
2022 |